![Alyssa Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alyssa Levin
No open positions remaining
Net worth: 333 652 $ as of 31/05/2026
Profile
Alyssa Levin formerly worked at ViaCyte, Inc., as Chief Financial Officer, Bird Rock Bio Sub, Inc., as Chief Financial Officer from 2019 to 2020, Tentarix Biotherapeutics, Inc., as Chief Financial Officer & Senior VP-Operations from 2020 to 2022, and Nkarta, Inc., as Chief Financial & Business Officer from 2023 to 2025.
Ms. Levin received her undergraduate degree from the University of British Columbia and graduate degree from Edwards School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NKARTA, INC. 0.14% | 15/01/2025 | 102,662 ( 0.14% ) | 333 652 $ | 31/05/2026 |
Former positions of Alyssa Levin
| Companies | Position | End |
|---|---|---|
| NKARTA, INC. | Director of Finance/CFO | 31/03/2025 |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Director of Finance/CFO | 05/07/2023 |
Tentarix Biotherapeutics, Inc.
 Tentarix Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for intelligent therapies with multifunctional biologics | Director of Finance/CFO | 02/01/2022 |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Director of Finance/CFO | 02/01/2020 |
Training of Alyssa Levin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bird Rock Bio Sub, Inc.
Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Edwards School of Business
 Edwards School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nkarta, Inc.
 Nkarta, Inc. BiotechnologyHealth Technology Discovers, develops and delivers NK cell therapies for cancer treatment | Health Technology |
Tentarix Biotherapeutics, Inc.
Tentarix Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company for intelligent therapies with multifunctional biologics | Health Technology |
- Stock Market
- Insiders
- Alyssa Levin
